Evidence map›Paper›PMID 12384382›Full record

ArticleAntimicrobial agents and chemotherapy2002

Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.

Manuel Cuenca-Estrella, Wendy Lee-Yang, Meral A Ciblak, Beth A Arthington-Skaggs, Emilia Mellado, David W Warnock, Juan L Rodriguez-Tudela

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Three-Component Synthesis of 2-Amino-3-cyano-4Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Can We Improve Antifungal Susceptibility Testing?Frontiers in cellular and infection microbiology · 2021
    Review
  13. Article
  14. Article
  15. Chemogenomic Profiling of the Fungal Pathogen Candida albicans.Antimicrobial agents and chemotherapy · 2018
    Article
  16. Synthesis and Antimicrobial Evaluation of 4Iranian journal of pharmaceutical research : IJPR · 2018
    Article
  17. Case reports in infectious diseases · 2017
    Article
  18. Macelignan inhibits bee pathogenic fungi Ascophaera apis growth through HOG1 pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manuel Cuenca-EstrellaServicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
Wendy Lee-Yang
Meral A Ciblak
Beth A Arthington-Skaggs
Emilia Mellado
David W Warnock
Juan L Rodriguez-Tudela

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A two-laboratory study was performed to evaluate the correlation between the NCCLS M27-A and EUCAST microdilution procedures for antifungal testing of Candida spp. A panel of 109 bloodstream isolates was tested against amphotericin B, flucytosine, fluconazole, and itraconazole. Overall, the agreement was 92% and the intraclass correlation coefficient was 0.90 (P < 0.05).

Indexed as

Antifungal AgentsCandidaCulture MediaEndpoint DeterminationMicrobial Sensitivity TestsReproducibility of ResultsAntifungal AgentsCulture Media

Identifiers

PMID12384382
PMCPMC128746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.